Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
36.44 -3.14%
Open in Risen →
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) is listed on NYSE in Pharmaceutical Stocks. It is $36.44, -3.14%, with a $42.5B market cap. RSI is 58.3, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 58.3 Neutral
Market Cap $42.5B
Volume 2.3M
Fundamentals — 10-Q Q2 2026
Revenue $8.1B
Net Income $-207.0M
EPS $-0.18
Gross Margin 50.8%
Operating Margin 5.2%
Net Margin -2.5%
P/E Ratio -202.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Weiss Amir | Chief Accounting Officer | Sell | 9,445 | $37.62 | $355,301 | 2026 Aug 21 |
| Satchi-fainaro Ronit | Insider | Sell | 415 | $37.25 | $15,459 | 2026 Aug 21 |
| Lippman Evan | EVP, Business Development | Sell | 18,600 | $36.57 | $680,291 | 2026 Aug 17 |
| Zaks Tal Zvi | Insider | Sell | 17 | $34.87 | $593 | 2026 Aug 5 |
| Jover Placid | See "Remarks" | Sell | 12,827 | $34.88 | $447,351 | 2026 Aug 3 |
| Hughes Eric A | See "Remarks" | Sell | 25,578 | $34.88 | $892,051 | 2026 Aug 3 |
| Shields Matthew | EVP, Global Operations | Sell | 9,989 | $32.19 | $321,547 | 2026 Jun 18 |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 106,563 | $34.10 | $3.6M | 2026 Jun 11 |
| Francis Richard D | President and CEO | Sell | 6,153 | $34.35 | $211,356 | 2026 Jun 5 |
| Shields Matthew | EVP, Global Operations | Sell | 16,195 | $32.87 | $532,330 | 2026 Jun 3 |
| Lippman Evan | EVP, Business Development | Sell | 41,658 | $35.58 | $1.5M | 2026 May 14 |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 153,251 | $35.61 | $5.5M | 2026 May 14 |
| Weiss Amir | Chief Accounting Officer | Sell | 10,679 | $36.00 | $384,444 | 2026 May 6 |
| Daniell Richard | EVP, Europe Commercial | Sell | 30,000 | $35.40 | $1.1M | 2026 May 5 |
| Sabag Mark | See "Remarks" | Sell | 144,180 | $34.99 | $5.0M | 2026 May 1 |
| Fox Christine | EVP, U.S. Commercial | Sell | 21,258 | $35.31 | $750,620 | 2026 Apr 30 |
| Sabag Mark | See "Remarks" | Sell | 62,102 | $30.14 | $1.9M | 2026 Mar 17 |
| Francis Richard D | President and CEO | Sell | 20,025 | $31.67 | $634,160 | 2026 Mar 5 |
| Fox Christine | EVP, U.S. Commercial | Sell | 7,924 | $31.67 | $250,940 | 2026 Mar 5 |
| Hughes Eric A | See "Remarks" | Sell | 9,533 | $31.67 | $301,895 | 2026 Mar 5 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $34.70 | 44.3 | $25.1B |
| | $153.79 | 49.7 | -- |
| | $20.85 | 65.2 | $2.2B |
| | $515.52 | 46.7 | $22.1B |
| | $13.17 | 50.0 | $2.7B |
Take TEVA further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put TEVA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Teva Pharmaceutical Industries Limited American Depositary Shares next reports.
Set alerts on TEVA
Get notified when Teva Pharmaceutical Industries Limited American Depositary Shares hits your price targets or technical conditions are met.
Get Started Free